Try our Advanced Search for more refined results
Your firm must have an account to access this feature
Track this case
Case overview
2:13-cv-01807
Pennsylvania Eastern
Other Statutes: Anti-Trust
Class Action
CYNTHIA M. RUFE
The U.S. Judicial Panel on Multidistrict Litigation on Wednesday selected Rhode Island for the centralization of six nationwide class actions accusing pharmaceutical company Warner Chilcott PLC of illegally muscling generic competitors for its oral contraceptive Loestrin out of the market.
Warner Chilcott PLC was hit with a class action on Friday alleging the drugmaker violated U.S. antitrust laws when it agreed to settle "sham" patent infringement litigation against Lupin Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. that delayed entry of generic versions of oral contraceptive Loestrin.